Staphylococcal vaccines and immunotherapies.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Infectious Disease Clinics of North America

• Publication date

  2009-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.idc.2008.10.005PMID 19135920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Staphylococcus aureus infections.

  2009cited by this paper
• Mupirocin Resistance in Patients Colonized with Methicillin-Resistant Staphylococcus aureus in a Surgical Intensive Care Unit

  2009cited by this paper
• Conjugate vaccines for preventing Haemophilus influenzae type b infections.

  2009cited by this paper
• Vaccine protection against Staphylococcus aureus pneumonia

  2008cited by this paper
• Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.

  2007cited by this paper
• Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.

  2007cited by this paper
• Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone

  2007cited by this paper
• Generation of Virulence Factor Variants in Staphylococcus aureus Biofilms

  2007cited by this paper
• Antibody for the prevention of neonatal noscocomial staphylococcal infection: a review of the literature.

  2007cited by this paper
• Conjugate vaccines for preventing Haemophilus influenzae type B infections.

  2007cited by this paper
• Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants.

  2007cited by this paper
• Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in men who have sex with men in New York City.

  2007cited by this paper
• Lack of effect of a booster dose of influenza vaccine in hemodialysis patients

  2007cited by this paper
• Phase II, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial of a Polyclonal Anti-Staphylococcus aureus Capsular Polysaccharide Immune Globulin in Treatment of Staphylococcus aureus Bacteremia

  2007cited by this paper
• Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005

  2007cited by this paper
• Skin and Soft-Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus

  2007cited by this paper
• Vancomycin-Resistant Staphylococcus aureus Isolates Associated with Inc18-Like vanA Plasmids in Michigan

  2007cited by this paper
• Molecular Mechanisms of agr Quorum Sensing in Virulent Staphylococci

  2007cited by this paper
• Molecular Basis for Preferential Protective Efficacy of Antibodies Directed to the Poorly Acetylated Form of Staphylococcal Poly-N-Acetyl-β-(1-6)-Glucosamine

  2007cited by this paper
• Infection control by antibody disruption of bacterial quorum sensing signaling.

  2007cited by this paper
• Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power.

  2007cited by this paper
• Capsular polysaccharide masks clumping factor A-mediated adherence of Staphylococcus aureus to fibrinogen and platelets.

  2007cited by this paper
• Surface adhesins of Staphylococcus aureus.

  2006cited by this paper
• Clinical practice. Prevention of meningococcal disease.

  2006cited by this paper
• Alpha‐toxin interferes with integrin‐mediated adhesion and internalization of Staphylococcus aureus by epithelial cells

  2006cited by this paper
• Antistaphylococcal vaccines and immunoglobulins: current status and future prospects.

  2006cited by this paper
• Human Immunoglobulin G Recognizing Fibrinogen-Binding Surface Proteins Is Protective against both Staphylococcus aureus and Staphylococcus epidermidis Infections In Vivo

  2006cited by this paper
• Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treat.

  2006cited by this paper
• Prevention of Meningococcal Disease

  2006cited by this paper
• Staphylococcus aureus small colony variants in prosthetic joint infection.

  2006cited by this paper
• Vaccine assembly from surface proteins of Staphylococcus aureus

  2006cited by this paper
• A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin

  2006cited by this paper
• Immunization with Staphylococcus aureus Clumping Factor B, a Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model

  2006cited by this paper
• Staphylococcus aureus IsdB Is a Hemoglobin Receptor Required for Heme Iron Utilization

  2006cited by this paper
• Staphylococcal vaccines and immunotherapy: to dream the impossible dream?

  2006cited by this paper
• A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis Model

  2006cited by this paper
• Molecular characterization of the capsule locus from non‐typeable Staphylococcus aureus

  2006cited by this paper
• Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage.

  2006cited by this paper
• Phase I Dose Escalation Study To Evaluate the Safety and Pharmacokinetic Profile of Tefibazumab in Subjects with End-Stage Renal Disease Requiring Hemodialysis

  2006cited by this paper
• Phase II, Randomized, Double-Blind, Multicenter Study Comparing the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of Staphylococcus aureus Bacteremia

  2006cited by this paper
• Multicenter Study to Assess Safety and Efficacy of INH-A21, a Donor-Selected Human Staphylococcal Immunoglobulin, for Prevention of Nosocomial Infections in Very Low Birth Weight Infants

  2005cited by this paper
• Comparative Opsonic and Protective Activities of Staphylococcus aureus Conjugate Vaccines Containing Native or Deacetylated Staphylococcal Poly-N-Acetyl-β-(1-6)-Glucosamine

  2005cited by this paper
• The role of epitope specificity in the human opsonic antibody response to the staphylococcal surface polysaccharide poly N-acetyl glucosamine.

  2005cited by this paper
• Nasal Carriage of Staphylococcus aureus and Prevention of Nosocomial Infections

  2005cited by this paper
• Immune evasion by staphylococci

  2005cited by this paper
• Heteropolymers: a novel technology against blood-borne infections.

  2005cited by this paper
• The role of nasal carriage in Staphylococcus aureus infections.

  2005cited by this paper
• Staphylococcus aureus Strains That Express Serotype 5 or Serotype 8 Capsular Polysaccharides Differ in Virulence

  2005cited by this paper
• Recognition and management of Staphylococcus aureus toxin‐mediated disease

  2005cited by this paper
• Regulatory and genomic plasticity of Staphylococcus aureus during persistent colonization and infection.

  2004cited by this paper
• Staphylococcus aureus Capsular Polysaccharides

  2004cited by this paper
• A humanized monoclonal antibody targeting Staphylococcus aureus.

  2004cited by this paper
• ATP-Binding Cassette Transporters Are Targets for the Development of Antibacterial Vaccines and Therapies

  2004cited by this paper
• Staphylococcus aureus bound to complement receptor 1 on human erythrocytes by bispecific monoclonal antibodies is phagocytosed by acceptor macrophages.

  2004cited by this paper
• Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers.

  2004cited by this paper
• Staphylococcus aureus Vaccine

  2003cited by this paper
• Passage of Heme-Iron Across the Envelope of Staphylococcus aureus

  2003cited by this paper
• Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene.

  2003cited by this paper
• Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitment.

  2003cited by this paper
• Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in an Experimental Model of Infective Endocarditis

  2003cited by this paper
• Passage of Heme-Iron Across the Envelope of Staphylococcus aureus

  2003cited by this paper
• Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

  2002cited by this paper
• Protection against Bacterial Superantigen Staphylococcal Enterotoxin B by Passive Vaccination

  2002cited by this paper
• Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

  2002cited by this paper
• Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.

  2002cited by this paper
• Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

  2002cited by this paper
• Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus

  2002cited by this paper
• Staphylococcus and biofilms

  2002cited by this paper
• Synthetic Lipoteichoic Acid from Staphylococcus aureus Is a Potent Stimulus of Cytokine Release

  2002cited by this paper
• Immunochemical Properties of the Staphylococcal Poly-N-Acetylglucosamine Surface Polysaccharide

  2002cited by this paper
• Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group.

  2001cited by this paper
• Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.

  2001cited by this paper
• Infections associated with uremia and dialysis.

  2001cited by this paper
• Structure–Function Relationship of Cytokine Induction by Lipoteichoic Acid fromStaphylococcus aureus

  2001cited by this paper
• The changing epidemiology of Staphylococcus aureus?

  2001cited by this paper
• Heteropolymer‐mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications

  2001cited by this paper
• Nasal Carriage as a Source of Staphylococcus aureus Bacteremia

  2001cited by this paper
• Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus.

  2001cited by this paper
• Adherence of Staphylococcus aureus to Endothelial Cells: Influence of Capsular Polysaccharide, Global Regulatoragr, and Bacterial Growth Phase

  2000cited by this paper
• Identification of an Immunodominant ABC Transporter in Methicillin-Resistant Staphylococcus aureusInfections

  2000cited by this paper
• Exotoxins of Staphylococcus aureus.

  2000cited by this paper
• The Intercellular Adhesion (ica) Locus Is Present in Staphylococcus aureus and Is Required for Biofilm Formation

  1999cited by this paper
• Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants

  1998cited by this paper
• Surface protein adhesins of Staphylococcus aureus.

  1998cited by this paper
• Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks

  1997cited by this paper
• Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats

  1997cited by this paper
• Structure of Staphylococcal α-Hemolysin, a Heptameric Transmembrane Pore

  1996cited by this paper
• Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis

  1996cited by this paper
• A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge

  1996cited by this paper
• Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines

  1996cited by this paper
• Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis.

  1996cited by this paper
• Passive immunization with antiserum to a nontoxic alpha-toxin mutant from Staphylococcus aureus is protective in a murine model

  1996cited by this paper
• Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis

  1995cited by this paper
• Use of adhesion-defective mutants of Staphylococcus aureus to define the role of specific plasma proteins in promoting bacterial adhesion to canine arteriovenous shunts

  1995cited by this paper
• Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus

  1994cited by this paper
• Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A

  1993cited by this paper
• Staphylococcus aureus microcapsule expression attenuates bacterial virulence in a rat model of experimental endocarditis.

  1992cited by this paper
• The Use of Vaccines in Renal Failure

  1992cited by this paper
• Occurrence and structure of lipoteichoic acids in the genus Staphylococcus

  1990cited by this paper
• Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A

  1990cited by this paper

• Lipid-coated nanoparticles enhance the delivery of bacterial virulence factors as a potent toxoid vaccine platform against bacterial infections.

  2025cites this paper
• Bacterial and host interactions in Staphylococcus aureus-induced septic arthritis—understanding pathogenesis and exploring therapeutic strategies

  2025cites this paper
• Potent human antibodies against SpA5 identified by high-throughput single-cell sequencing of phase I clinical volunteers’ B cells

  2024cites this paper
• Coexistence of the blaZ gene and selected virulence determinants in multidrug-resistant Staphylococcus aureus: insights from three Nigerian tertiary hospitals

  2024cites this paper
• Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies

  2023cites this paper
• Profiling of serum factors associated with Staphylococcus aureus skin and soft tissue infections as a foundation for biomarker identification

  2023cites this paper
• PEI‐PLGA nanoparticles significantly enhanced the immunogenicity of IsdB137‐361 proteins from Staphylococcus aureus

  2023cites this paper
• Als3‐Th‐cell‐epitopes plus the novel combined adjuvants of CpG, MDP, and FIA synergistically enhanced the immune response of recombinant TRAP derived from Staphylococcus aureus in mice

  2021cites this paper
• Pathogenicity and virulence of Staphylococcus aureus

  2021cites this paper
• Intracellular escape strategies of Staphylococcus aureus in persistent cutaneous infections

  2020cites this paper
• Protein glycosylation: Sweet or bitter for bacterial pathogens?

  2019cites this paper
• TLR2 agonist Pam3CSK4 enhances the antibacterial functions of GM-CSF induced neutrophils to methicillin-resistant Staphylococcus aureus.

  2019cites this paper
• Staphylococcus aureus heme and siderophore-iron acquisition pathways

  2019cites this paper
• Staphylococcus aureus clumping factor A is a force-sensitive molecular switch that activates bacterial adhesion

  2018cites this paper
• The development of a staphylococcus aureus four antigen vaccine for use prior to elective orthopedic surgery

  2018cites this paper
• Staphylococcus aureus vaccine preclinical and clinical development: current state of the art.

  2018cites this paper
• The role of vaccines in preventing bacterial antimicrobial resistance

  2018cites this paper
• Staphylococcal Biofilms

  2018cites this paper
• Next-generation sequencing to monitor the spread of antimicrobial resistance

  2017cites this paper
• An Update on Clinical Burden, Diagnostic Tools, and Therapeutic Options of Staphylococcus aureus

  2017cites this paper
• A novel bivalent fusion vaccine induces broad immunoprotection against Staphylococcus aureus infection in different murine models.

  2017cites this paper
• Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo

  2017cites this paper
• Artificial opsonin enhances bacterial phagocytosis, oxidative burst and chemokine production by human neutrophils

  2017cites this paper
• Pathogenic Mechanisms and Host Interactions in Staphylococcus epidermidis Device-Related Infection

  2017cites this paper
• Guidelines for vaccination in patients with chronic kidney disease

  2016cites this paper
• Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA–IsdB–Hlg as a vaccine candidate

  2016cites this paper
• Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models

  2016cites this paper
• Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial

  2015cites this paper
• The Fall of a Dogma? Unexpected High T-Cell Memory Response to Staphylococcus aureus in Humans.

  2015cites this paper
• Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study

  2015cites this paper
• Successful selection of an infection‐protective anti‐Staphylococcus aureus monoclonal antibody and its protective activity in murine infection models

  2015cites this paper
• Inhibition of Virulence as Treatment Strategies for Staphylococcus aureus Infection

  2015cites this paper
• Pathogenesis of Staphylococcus aureus in Humans

  2015cites this paper
• Targeting Surface Protein SasX by Active and Passive Vaccination To Reduce Staphylococcus aureus Colonization and Infection

  2015cites this paper
• Evaluation of recombinant SEA-TSST fusion toxoid for protection against superantigen induced toxicity in mouse model.

  2015cites this paper
• In silico analysis for identifying potential vaccine candidates against Staphylococcus aureus

  2015cites this paper
• Where does a Staphylococcus aureus vaccine stand?

  2014cites this paper
• Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.

  2014cites this paper
• Targeting Pili in Enterococcal Pathogenesis

  2014cites this paper
• Antistaphylococcal Conjugate Vaccine (Poly)Glycerolphosphate-Based Novel Synthetic

  2014cites this paper
• Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli.

  2014cites this paper
• Anti-biofilm agents: recent breakthrough against multi-drug resistant Staphylococcus aureus.

  2014cites this paper
• Article Commentary: The Continued Challenge of Staphylococcus aureus in the Surgical Patient

  2013cites this paper
• The importance of phenol-soluble modulins in Staphylococcus aureus infections

  2013cites this paper
• Novel Synthetic (Poly)Glycerolphosphate-Based Antistaphylococcal Conjugate Vaccine

  2013cites this paper
• Synthesized in Escherichia coli

  2013cites this paper
• The expression of a putative exotoxin and an ABC transporter during bovine intramammary infection contributes to the virulence of Staphylococcus aureus.

  2013cites this paper
• Targeting agr- and agr-Like Quorum Sensing Systems for Development of Common Therapeutics to Treat Multiple Gram-Positive Bacterial Infections

  2013cites this paper
• Oral immunization with Lactococcus lactis secreting attenuated recombinant staphylococcal enterotoxin B induces a protective immune response in a murine model

  2013cites this paper
• Predictors of Mortality in Staphylococcus aureus Bacteremia

  2012cites this paper
• Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections.

  2012cites this paper
• Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity

  2012cites this paper
• Preserving immunogenicity of lethally irradiated viral and bacterial vaccine epitopes using a radio- protective Mn2+-Peptide complex from Deinococcus.

  2012cites this paper
• Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

  2012cites this paper
• Challenges for a universal Staphylococcus aureus vaccine.

  2012cites this paper
• Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors

  2012cites this paper
• Generation and characterization of an inter‐generic bivalent alpha domain fusion protein αCS from Clostridium perfringens and Staphylococcus aureus for concurrent diagnosis and therapeutic applications

  2012cites this paper
• Is there a future for a Staphylococcus aureus vaccine?

  2012cites this paper
• Anti-bacterial monoclonal antibodies: back to the future?

  2012cites this paper
• Determinants of Murein Hydrolase Targeting to Cross-wall of Staphylococcus aureus Peptidoglycan*

  2012cites this paper
• Controlling Antimicrobial Resistance through Targeted, Vaccine-Induced Replacement of Strains

  2012cites this paper
• Staphylococcus aureus harbouring Enterotoxin A as a possible risk factor for multiple sclerosis exacerbations

  2011cites this paper
• Targeting the host–pathogen interface for treatment of Staphylococcusaureus infection

  2011cites this paper
• Antibody responses in furunculosis patients vaccinated with autologous formalin-killed Staphylococcus aureus

  2011cites this paper
• Innate immune responses of preterm infants to coagulase-negative staphylococci

  2011cites this paper
• Distinctive patterns in the human antibody response to Staphylococcus aureus bacteremia in carriers and non‐carriers

  2011cites this paper
• Staphylococcus aureus: Emerging Concepts in Vaccine Development

  2011cites this paper
• Clostridium difficile and methicillin-resistant Staphylococcus aureus: emerging concepts in vaccine development.

  2011cites this paper
• Monoclonal antibodies in infectious diseases: clinical pipeline in 2011.

  2011cites this paper
• An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children

  2011influential citation
• Neutrophils in innate host defense against Staphylococcus aureus infections

  2011cites this paper
• Peptide mimics of peptidoglycan are vaccine candidates and protect mice from infection with Staphylococcus aureus.

  2011cites this paper
• Development of a vaccine against Staphylococcus aureus

  2011cites this paper
• Immunotherapeutic approaches against Staphylococcus aureus.

  2011cites this paper
• Expectations regarding vaccines and immune therapies directed against Staphylococcus aureus alpha-hemolysin.

  2011cites this paper
• Characteristics of Staphylococcus aureus infections to consider in designing an effective vaccine.

  2010cites this paper
• Antibody responses in patients with invasive Staphylococcus aureus infections

  2010influential citation
• The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus.

  2010cites this paper
• Progress in the Development of Effective Vaccines to Prevent Selected Gram-Positive Bacterial Infections

  2010cites this paper
• Towards the immune proteome of Staphylococcus aureus - The anti-S. aureus antibody response.

  2010cites this paper
• Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections?

  2010cites this paper
• Basis of Virulence in

  2010cites this paper
• New insights into the prevention of staphylococcal infections and toxic shock syndrome

  2010cites this paper
• Apolipoprotein B-mediated control of Staphylococcus aureus virulence

  2010cites this paper
• Anti-virulence paradigm for development of staphylococcal therapies

  2010cites this paper
• The Staphylococcus aureus

  2010cites this paper
• Host-pathogen interactions of secreted and surface Staphylococcus aureus factors

  2010cites this paper
• Novel targeted immunotherapy approaches for staphylococcal infection

  2010cites this paper
• TLR2 Mediates Recognition of Live Staphylococcus epidermidis and Clearance of Bacteremia

  2010cites this paper
• Structural biology of heme binding in the Staphylococcus aureus Isd system.

  2010cites this paper
• Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus.

  2010cites this paper
• Staphylococcus aureus: An old pathogen with new weapons.

  2010cites this paper
• Innovative management of recurrent furunculosis.

  2010cites this paper
• Serum antibodies against Staphylococcus aureus antigens in healthy individuals and patients with invasive infections

  2010cites this paper
• The presence of both bone sialoprotein-binding protein gene and collagen adhesin gene as a typical virulence trait of the major epidemic cluster in isolates from orthopedic implant infections.

  2009cites this paper
• Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population-based study.

  2009cites this paper
• Iron and copper homeostasis in Staphylococcus aureus

  2009cites this paper
• Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice

  2009cites this paper
• Invasive Staphylococcus aureus infections

  2009cites this paper